Login / Signup

Tenofovir Versus Entecavir on Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma After Surgical Resection.

Jonggi ChoiChanyoung JoYoung Suk Lim
Published in: Hepatology (Baltimore, Md.) (2020)
Among patients who underwent curative hepatectomy for HBV-related HCC, TDF therapy was associated with a significantly lower risk of HCC recurrence and better overall patient survival compared with ETV therapy.
Keyphrases
  • hepatitis b virus
  • free survival
  • liver failure
  • acute lymphoblastic leukemia
  • case report
  • stem cells
  • mesenchymal stem cells
  • antiretroviral therapy
  • cell therapy
  • prognostic factors